Literature DB >> 3871375

Development of hyporesponsiveness to augmentation of natural killer cell activity after multiple doses of maleic anhydride divinyl ether: association with decreased numbers of large granular lymphocytes.

T Saito, R D Welker, H Fukui, R B Herberman, M A Chirigos.   

Abstract

A single injection of mice with maleic anhydride divinyl ether (MVE-2) resulted in significantly augmented natural killer (NK) activity. However, multiple injections with MVE-2 led to a hyporesponsive to boosting of NK activity. Stimulation of prostaglandin E secretion of induction of suppressor macrophages (M phi) or lymphocytes were shown not to be responsible for the depressed NK cell responses. Rather the hyporesponsiveness to NK boosting was associated with a decreased number of large granular lymphocytes (LGLs). Percoll discontinuous-density-gradient studies showed that the augmented NK activity of spleen cells after a single injection with MVE-2 was associated with an increase in the percentage of LGLs in the lower-density fractions (Fraction 1 and 2). In contrast, the NK activity and percentage of LGLs in the lower-density fractions were markedly decreased after multiple injections with MVE-2. Polyinosinic: polycytidylic acid stabilized with poly(L-lysine) in carboxymethylcellulose, another BRM capable of augmenting NK activity, was able to substantially augment NK activity in mice hyporesponsive to MVE-2 and this was accompanied by an increase in the percentage of LGLs in the lower-density Percoll fractions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871375     DOI: 10.1016/0008-8749(85)90222-9

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  6 in total

1.  Augmentation of natural cell activity in tumor-bearing and normal mice by MVE-2.

Authors:  W Budzynski; M Chirigos; E Gruys
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Modulation of natural killer activity by thymosin alpha 1 and interferon.

Authors:  C Favalli; T Jezzi; A Mastino; C Rinaldi-Garaci; C Riccardi; E Garaci
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

3.  Permanent large granular lymphocytosis in the blood of splenectomized individuals without concomitant increase of in vitro natural killer cell cytotoxicity.

Authors:  E Kelemen; P Gergely; D Lehoczky; E Triska; J Demeter; P Vargha
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

Review 4.  Enhanced immune response and antitumor immunity with combinations of biological response modifiers.

Authors:  E Garaci; A Mastino; C Favalli
Journal:  Bull N Y Acad Med       Date:  1989-01

5.  Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study.

Authors:  Daniele Pastori; Roberto Carnevale; Cristina Nocella; Simona Bartimoccia; Marta Novo; Vittoria Cammisotto; Silvia Piconese; Maria Santulli; Fortunata Vasaturo; Francesco Violi; Pasquale Pignatelli
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

Review 6.  NK Cell Hyporesponsiveness: More Is Not Always Better.

Authors:  Marie Frutoso; Erwan Mortier
Journal:  Int J Mol Sci       Date:  2019-09-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.